4KILCIKSIZ S, KARAKOYUN-CELIK O, AGAOGLU F Y,et al. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma[J]. Scientific World J,2012,2012:8957-8965.
5MORARIU I, BURNS P, ROCHE P, et al. Triple manifestation of extramedullary plasmacytoma in the upper airway: an unusual clinical entity[J]. J Laryn- gol Otol,2011,125 : 970-972.
6McCarthy PL, Hahn T. Strategies for induction, autologous hema- topoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients[J]. Hematolo- g'y Am Soc Hematol Educ Program, 2013, 2013:496-503.
7Papanikolaou X, Repousis P, Tzenou T, et al. Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse[J]. Leuk Lympho- ma, 2013.54(7):1459-1464.
8Palumbo A, Sezer O, Kyle R, et al. International Myeloma Working Group guidelines for the management of muldple myeloma patients hleligible for standard high-dose chemotherapy with autologous stem cell transplantation[J]. Leukemia, 2009, 23(10):1716-1730.
9NCCN clinical practice guidelines in oncology (NCCN Guidelines TM), version 2, Multiple Myeloma, 2014, 12-15.
10Durie BG, HarousseauJL, MiguelJS, et al. International Myeloma Working Group. International uniform response criteria for multi- ple myeloma[J]. Leukemia, 2006, 20(9):1467-1473.
